SMTL ID : 5eym.2 (1 other biounit)

MEK1 IN COMPLEX WITH BI 847325

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.70 Å

Oligo State

monomer

Ligands

1 x 5U5: 3-[(3~{Z})-3-[[[4-[(dimethylamino)methyl]phenyl]amino]-phenyl-methylidene]-2-oxidanylidene-1~{H}-indol-6-yl]-~{N}-ethyl-prop-2-ynamide(Non-covalent)

5U5.1: 15 residues within 4Å: Chain A: L.40, G.41, V.48, A.61, K.63, L.84, I.107, M.109, E.110, H.111, M.112, G.115, Q.119, L.163, D.174 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:L.40, A:V.48, A:V.48, A:L.84, A:I.107, A:L.163 Hydrogen bonds: A:E.110, A:M.112, A:M.112, A:D.174 Water bridges: A:K.63

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Sini, P. et al., Pharmacological Profile of BI 847325, an Orally Bioavailable, ATP-Competitive Inhibitor of MEK and Aurora Kinases. Mol.Cancer Ther. (2016)

Release Date

2016-08-17

Peptides

Dual specificity mitogen-activated protein kinase kinase 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Dual specificity mitogen-activated protein kinase kinase 1

Related Entries With Identical Sequence